Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
26.50    0.00 (0.00%)
Bid:
26.00
Ask:
27.00
Spread: 1.00 (3.846%)
Market Cap: £114.06m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Deferred Consideration and Board Change

26 Mar 2018 07:00

RNS Number : 8338I
Mercia Technologies PLC
26 March 2018
 

RNS

26 March 2018

 

Mercia Technologies PLC("Mercia" or the "Group")

Deferred Consideration and Board Change

 

Mercia Technologies PLC (AIM: MERC), the national investment group focused on the funding and scaling of innovative technology businesses with high growth potential from the UK regions, is pleased to announce the full payment of the deferred consideration for the acquisition of Enterprise Ventures Group Limited ("Enterprise Ventures"), details of which were originally announced on 10 March 2016. The trigger for the payment of the £2.0million deferred consideration target (adjusted to £1.98million to take into account one Enterprise Ventures Seller ceasing to be an employee of the Group) was Enterprise Ventures successfully being awarded at least £80.0million in net new fund mandates during the two-year period following Mercia's acquisition. In fact, Enterprise Ventures has significantly outperformed this target, having been awarded £178.0million in net new fund mandates during this period, which is a very positive outcome for Mercia.

 

Mercia has deducted, and will settle, the Sellers' income tax and employees' national insurance liabilities arising from the receipt of the deferred consideration. The net deferred consideration is being settled by the issue of 2,707,475 Ordinary shares (the "Deferred Consideration Shares"). The value of each Deferred Consideration Share is 39.9 pence and is based on the average closing mid-market price for the five days ended 23 March 2018.

 

Application has been made for the Deferred Consideration Shares to be admitted to trading on the AIM market of the London Stock Exchange ("Admission") and it is expected that Admission will become effective at 8.00 a.m. on 29 March 2018. The Sellers include two Persons Discharging Managerial Responsibilities ("PDMRs").

 

Following Admission, Julian Viggars and John Simpson (both PDMRs) will hold the following Ordinary shares and options:

 

PDMR

Deferred Consideration Shares

Total number of Ordinary shares

Number of options over Ordinary shares

Julian Viggars

231,004

424,325*

400,000

John Simpson

481,317

754,997

250,000

 

*Including 75,000 Ordinary shares held by Mrs Emma Viggars

 

Following Admission, the Company will have 303,309,707 Ordinary shares in issue. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Mercia under the FCA's Disclosure Guidance and Transparency Rules.

 

Board Change

 

Mercia Technologies also announces that following the wholly successful integration of Enterprise Ventures, Jonathan Diggines, its former Chief Executive, who joined the Board of Mercia as an Executive Director upon completion of the acquisition, has notified Mercia that he believes that this is the right time for him to relinquish his Mercia directorships. He will continue to work with the team at Mercia Fund Managers, the Group's growing and profitable fund management business, by participating in the investment decision-making process as a member of Mercia's numerous funds' Investment Committees. In particular, he will chair the new £45.1million Enterprise Ventures Growth II fund, which closed in December 2017.

 

Dr Mark Payton, CEO of Mercia Technologies PLC, said:

 

"Today's announcement of the significant overachievement of the Enterprise Ventures' deferred consideration target is another milestone in Mercia's evolution and demonstrates the Group's ability to identify, evaluate, price, acquire and successfully integrate value-adding acquisitions.

 

"I would like to take this opportunity to thank Jonathan Diggines for his significant personal contribution towards achieving the successful integration of Enterprise Ventures into the Group, where it has continued to flourish and grow. Jonathan's continuing involvement within Mercia can only be a catalyst for further investment success in the future."

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information, please contact

Mercia Technologies PLC

+44 (0)330 223 1430

Mark Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.merciatech.co.uk

Cenkos Securities plc

+44 (0)20 7397 8900

Stephen Keys, Camilla Hume (NOMAD and Joint Broker)

Canaccord Genuity Limited

+44 (0)20 7523 8000

Simon Bridges, Emma Gabriel (Joint Broker)

Buchanan

+44 (0)20 7466 5000

Bobby Morse, Chris Lane, Stephanie Watson

www.buchanan.uk.com

About Mercia Technologies PLC

Mercia is a national investment group focused on the funding and scaling of innovative technology businesses with high growth potential from the UK regions. Mercia benefits from 19 university partnerships and offices across the Midlands, the North of England and Scotland providing it with access to high quality, regional deal flow. Mercia Technologies PLC is quoted on AIM with the epic "MERC".

 

Mercia's 'Complete Capital Solution' initially nurtures businesses via its third party funds (now with circa £350.0million under management following recent mandate wins) and then over time Mercia can provide further funding to its 'Emerging Stars' by deploying direct investment follow-on capital from its own balance sheet. Since its IPO in December 2014, Mercia has invested over £46.0million directly across its portfolio of 'Emerging Stars'.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUPAWUPRGMW
Date   Source Headline
24th Sep 20103:41 pmRNSHolding(s) in Company
22nd Sep 201011:31 amRNSResult of AGM
22nd Sep 20107:00 amRNSAGM Statement
23rd Jul 20107:00 amRNSDirector Shareholding
22nd Jul 20107:00 amRNSFinal Results
12th Jul 201012:42 pmRNSChange of Registered Office
30th Jun 201010:38 amRNSChange of Name
22nd Jun 20107:00 amRNSSenior Appointments
8th Jun 20107:00 amRNSPosting of Circular & Notice of General Meeting
28th Apr 20103:53 pmRNSHolding(s) in Company
21st Apr 20107:00 amRNSTrading Update
1st Feb 20107:00 amRNSAppointment of Head of Corporate Finance
8th Dec 20097:00 amRNSInterim Results
15th Oct 20097:00 amRNSJohn East & Partners Limited changes its name
23rd Sep 200910:10 amRNSAGM Statement
22nd Sep 20091:12 pmRNSHolding(s) in Company
22nd Sep 20097:00 amRNSDirector/PDMR Shareholding
10th Sep 20097:00 amRNSMerchant Securities announces New Share Option Sch
7th Sep 20097:00 amRNSAcquisition
25th Aug 20093:46 pmRNSAnnual Financial Report
30th Jul 20097:00 amRNSFinal Results
1st Jun 20092:17 pmRNSNotification of major interest in shares
6th May 20093:55 pmRNSFundraising completed
28th Apr 20097:00 amRNSTrading Statement
27th Nov 20087:00 amRNSInterim Results
24th Nov 20081:44 pmRNSNotice of Results
10th Nov 20087:00 amRNSDirector appointment
24th Sep 200810:55 amRNSAGM Statement
12th Sep 20085:00 pmRNSAnnual Report and Accounts
21st Aug 20087:00 amRNSFinal Results
15th Aug 200812:12 pmRNSNotice of Results
8th Aug 20087:00 amRNSDirectorate Change
28th Jul 200812:15 pmRNSNotification of Major interes
24th Jul 20085:06 pmRNSStatement re Major Interest i
22nd Jul 200810:07 amRNSDirector/PDMR Shareholding
21st Jul 20082:43 pmRNSEGM Statement
2nd Jul 20087:00 amRNSCity team joins Merchant Secu
27th Jun 20087:00 amRNSCapital Reorganisation
17th Jun 20081:19 pmRNSStatement re FSA Settlement
13th Jun 200811:30 amRNSDirectorate Change
1st May 20087:01 amRNSTrading Update
28th Mar 200812:22 pmRNSEGM Statement
25th Mar 200810:41 amRNSDirectorate Change
3rd Mar 200810:22 amRNSGeneral Meeting
15th Feb 20087:00 amRNSFormal Notice
21st Dec 20077:01 amRNSInterim Results
31st Oct 20074:29 pmRNSTotal Voting Rights
12th Oct 20077:00 amRNSHolding(s) in Company
9th Oct 20075:20 pmRNSFormal Notice
4th Oct 20077:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.